MMP-2 Inhibitor I Size:Contact [email protected] for quotation Smiles: CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C=C1O)C1SC=NC=1C)C(C)(C)C

Smiles: CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C=C1O)C1SC=NC=1C)C(C)(C)C

30 min before the experiment

In functional experiments

Compared with the control group

60 min) weakly displaces [3H]-flunitrazepam binding to rat brain synaptosomal membranes by 5-10%

MMP-2 Inhibitor I Size:Contact [email protected] for quotation Smiles: CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C=C1O)C1SC=NC=1C)C(C)(C)CMMP 2 Inhibitor I, a hydroxamate based, long chain fatty acid, is a reversible inhibitor of matrix metalloproteinase (MMP) 2. Matrix metalloproteinases (MMPs) have been involved in the degradation of extracellular matrix. MMPs contribute to long term remodeling processes such as embryogenesis, tumor invasion, inflammation, angiogenesis, and wound healing. MMP 2, also known as gelatinase A or type IV collagenase, has been involved in regulating diverse